NCT01346618

Brief Summary

Bone age assessment is currently an important tool in final height implication in children. It is an important tool in the phases of investigation and treatment of short stature, tall stature, pubertal timing and various endocrinological pediatric situations. It is currently assessed using hand x-ray. This method has several limitations, including: requirement of specialized medical staff to interpret results, exposure radiation and usage of equipment which is only in radiology centers. The investigators aim to study a new equipment, radiation free, with simple and swift operation which provides an immediate answer, no need for an experienced observer, a mobile equipment with easy accessibility. The aim of the study is to assess its reproducibility, validity and safety compared to the x-ray method. The investigators hypothesize it is as accurate and valid.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 25, 2011

Completed
6 days until next milestone

Study Start

First participant enrolled

May 1, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 3, 2011

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2013

Completed
Last Updated

December 6, 2022

Status Verified

December 1, 2022

Enrollment Period

1.8 years

First QC Date

April 25, 2011

Last Update Submit

December 5, 2022

Conditions

Keywords

bone agechildrenx-rayultrasoundultrasound based methodsafevalidreproducable

Outcome Measures

Primary Outcomes (1)

  • BA assessment readings by the SonicBone's BA device compared to the traditional GP method based reading of left hand x-ray and their reproducibility

    9 months

Secondary Outcomes (1)

  • The number of participants experiencing adverse side affects

    9 months

Study Arms (1)

children ages 4-17 years

Participants are children and youth ages 4-17 years (inclusive) who performed or will perform a X-ray of the left hand for bone age assessment as part of any clinical work up, within 2 months of enrollment in this study.

Eligibility Criteria

Age4 Years - 17 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Participants are children and youth ages 4-17 years (inclusive) who performed or will perform a X-ray of the left hand for bone age assessment as part of any clinical work up, within 2 months of enrollment in this study. Participants will be recruited according to advertising the study amongst pediatricians, pediatric endocrinologists and from the pediatric population who visits the pediatric endocrine clinic, endocrine testing room, adolescent medicine clinic, or being hospitalized at the pediatric division, Assaf Haroffeh Medical Center.

You may qualify if:

  • Children aged 4-17 years old
  • Children who performed or will perform a hand x-ray as part of their clinical work up within 2 months from study enrolment
  • A signed Informed Consent Form that was obtained from at least one parent or legal guardian and an audio approval by the other (phone call), if available, prior to ultrasound study.
  • An assent from the child to perform the SonicBone's BA device reading

You may not qualify if:

  • Children taking any medication that might change bone metabolism or mineralization within the last year (glucocorticosteroids, sex steroids, oral contraceptives, anticonvulsants, calcium and vitamin D in superphysiological doses)
  • Children with suspected bone diseases or multiple fractures.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assaf Haroffeh Medical Center

Ẕerifin, 70300, Israel

Location

Study Officials

  • Marianna Rachmiel, MD

    Assaf Haroffeh Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Marianna Rachmiel

Study Record Dates

First Submitted

April 25, 2011

First Posted

May 3, 2011

Study Start

May 1, 2011

Primary Completion

March 1, 2013

Study Completion

March 1, 2013

Last Updated

December 6, 2022

Record last verified: 2022-12

Locations